World's Best Scientists 2026 revealed!
Lawrence A. Leiter

Lawrence A. Leiter

D-Index & Metrics

Medicine

D-Index
143
Citations
101795
World Ranking
1478
National Ranking
45

Lawrence A. Leiter publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Lawrence A. Leiter sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 804 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Lawrence A. Leiter D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Lawrence A. Leiter sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 143 D-Index — 93rd percentile

93% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Lawrence A. Leiter is affiliated with the University of Toronto in Canada and has a research focus primarily in the field of Medicine, with significant contributions in Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Molecular Biology, and Economics and Econometrics. Their work spans multiple interconnected areas reflecting interdisciplinary approaches within medical science.

The scientist's research concentrates strongly on topics such as Diabetes Treatment and Management, Lipoproteins and Cardiovascular Health, Metabolism, Diabetes, and Cancer, Diabetes Management and Research, Diet and metabolism studies, Diabetes, Cardiovascular Risks, and Lipoproteins, as well as Pancreatic function and diabetes.

Lawrence A. Leiter has published extensively in high-profile journals, with frequent publication venues including:

  • Journal of the American College of Cardiology
  • Circulation
  • Diabetes Obesity and Metabolism
  • Diabetes Care
  • European Heart Journal

Among recent notable papers authored or co-authored by Leiter are:

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure (2020) - New England Journal of Medicine
  • Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol (2020) - New England Journal of Medicine
  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease (2020) - New England Journal of Medicine
  • 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults (2021) - Canadian Journal of Cardiology
  • Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia (2020) - New England Journal of Medicine

Lawrence A. Leiter collaborates frequently with several researchers, indicating strong scientific networks in their discipline. Notable co-authors include:

  • Deepak L. Bhatt
  • Kausik K. Ray
  • Darren K. McGuire
  • Wolfgang Köenig
  • Frederick J. Raal

Best Publications

  • Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

    Steven P. Marso;Stephen C. Bain;Agostino Consoli;Freddy G. Eliaschewitz

  • Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus

    Benjamin M. Scirica;Deepak L. Bhatt;Deepak L. Bhatt;Eugene Braunwald;P. Gabriel Steg

  • Effects of combination lipid therapy in type 2 diabetes mellitus.

    Henry N. Ginsberg;Laura C. Lovato;Lawrence A. Leiter;Peter Linz

  • SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.

    Thomas A Zelniker;Stephen D Wiviott;Itamar Raz;Kyungah Im

  • Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome

    Gregory G. Schwartz;Anders G. Olsson;Markus Abt;Christie M. Ballantyne

  • Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    Adrian F Hernandez;Jennifer B Green;Salim Janmohamed;Ralph B D'Agostino

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  • Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure

    Deepak L. Bhatt;Michael Szarek;P. Gabriel Steg;Christopher P. Cannon

  • 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

    Todd J. Anderson;Jean Grégoire;Glen J. Pearson;Arden R. Barry

  • Two Phase 3 Trials of Inclisiran in Patients With Elevated LDL Cholesterol

    Kausik K. Ray;R. Scott Wright;David Kallend;Wolfgang Koenig;Wolfgang Koenig

  • Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol.

    Kausik K Ray;Ulf Landmesser;Lawrence A Leiter;David Kallend

  • Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Salim Yusuf;Jackie Bosch;Gilles Dagenais;Jun Zhu

  • Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial

    William T Cefalu;William T Cefalu;Lawrence A Leiter;Kun-Ho Yoon;Pablo Arias

  • Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.

    Deepak L. Bhatt;Michael Szarek;Bertram Pitt;Christopher P. Cannon

  • Effect of valsartan on the incidence of diabetes and cardiovascular events.

    John McMurray;R Holman;Steven Haffner;M Bethel

  • Effects of a Dietary Portfolio of Cholesterol-Lowering Foods vs Lovastatin on Serum Lipids and C-Reactive Protein

    David J. A. Jenkins;Cyril W. C. Kendall;Augustine Marchie;Dorothea A. Faulkner

  • Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease

    Eva M. Lonn;Eva M. Lonn;Jackie Bosch;Jackie Bosch;Patricio Lopez-Jaramillo;Jun Zhu

  • Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus.

    Thomas A. Zelniker;Stephen D. Wiviott;Itamar Raz;KyungAh Im

  • Hypertension Canada’s 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children

    Kara A. Nerenberg;Kelly B. Zarnke;Alexander A. Leung;Kaberi Dasgupta

  • Inclisiran for the Treatment of Heterozygous Familial Hypercholesterolemia

    Frederick J. Raal;David Kallend;Kausik K. Ray;Traci Turner

Frequent Co-Authors

Deepak L. Bhatt
Deepak L. Bhatt Mount Sinai Hospital
Shaun G. Goodman
Shaun G. Goodman University of Toronto
Darren K. McGuire
Darren K. McGuire The University of Texas Southwestern Medical Center
Itamar Raz
Itamar Raz Hebrew University of Jerusalem
Kausik K. Ray
Kausik K. Ray Imperial College London
Marc S. Sabatine
Marc S. Sabatine Brigham and Women's Hospital
Stephen D. Wiviott
Stephen D. Wiviott Brigham and Women's Hospital
Cyril W.C. Kendall
Cyril W.C. Kendall University of Toronto
John P.H. Wilding
John P.H. Wilding University of Liverpool
Subodh Verma
Subodh Verma University of Toronto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in healthcare careers besides traditional medical school, a variety of flexible online degree options are available. Advancements in technology have made it possible to pursue programs like nursing school online, allowing students to balance education with work and personal commitments.

Registered Nurses looking to enhance their credentials may consider an rn to bsn online program, which offers the opportunity to advance in clinical practice or leadership roles. For those aiming to teach or reach the highest levels of nursing, accredited doctorate in nursing education online programs provide advanced skills in research, policy, and academia.

Even those without a prior nursing background can take advantage of direct entry online msn programs designed for non-nurses, accelerating entry into nursing careers. These flexible online pathways can open doors to rewarding roles in patient care, administration, and education within the growing U.S. healthcare system.

Best Scientists Citing Lawrence A. Leiter

Trending Scientists

Recently Published Articles